Exchange: NASDAQ·Updated 12:06 PM EDT
BCTX logo

BCTX BriaCell Therapeutics Corp

$3.55
$0.0153
(0.43%)
Today
Reported EarningsJun 10
Mkt Cap$31.06M
Vol26,911.00

About BCTX

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.
30

Bearish Sentiment

How do you feel about BCTX?

Advertisement|Remove ads.